Home / Tue 30 Jul 2024 Market Recap
30 Jul 2024: Nifty 50 closes at ₹24,840.90 (+0.01%). Bharat Petroleum on 5-day win streak, Ajanta Pharma closing higher for 9 days.
Show Table of Contents
Table of Contents
- 1: Top Indices Performance Overview
- 2: Nifty 50 Performance Overview
- 2.1: Nifty 50 Top Gainers
- 2.2: Nifty 50 Top Losers
- 2.3: Nifty 50 Stocks To Watch for Tomorrow
- 2.3.1: Bharat Petroleum (Bullish Pattern)
- 2.3.2: ➲ Nestle India (Bearish Trend)
- 3: Nifty 500 Performance Overview
- 3.1: Nifty 500 Top Gainers
- 3.2: Nifty 500 Top Losers
- 3.3: Nifty 51 to 500 Stocks To Watch for Tomorrow
- 3.3.1: Ajanta Pharma: A Look at the Bullish Trend
- 3.3.2: ➲ Poly Medicure (Bearish Trend)
- 4: Top Stocks That Created a New All Time High Today
- 4.1: Top Large Cap Stocks That Created a New All Time High Today
- 4.2: Top Mid Cap Stocks That Created a New All Time High Today
- 4.3: Top Small Cap Stocks That Created a New All Time High Today
Top Indices Performance Overview
Stock | Close | Range |
---|---|---|
NIFTY 50 | ₹24,840.9 (0.01%) | ₹24,798.65 – ₹24,971.75 |
NIFTY BANK | ₹51,426.14 (0.03%) | ₹51,267.1 – ₹51,952.75 |
NIFTY FIN SERVICE | ₹23,300.4 (-0.07%) | ₹23,208.34 – ₹23,583.84 |
NIFTY IT | ₹40,758.5 (-0.16%) | ₹40,564.94 – ₹40,881.14 |
NIFTY ENERGY | ₹43,908.35 (1.08%) | ₹43,499.75 – ₹44,341.8 |
Nifty 50 Performance Overview
The Nifty 50 started the day at ₹24,850.19, showing a bit of a roller coaster ride throughout the session. It dipped to a low of ₹24,798.65 before climbing to a high of ₹24,971.75. In the end, it closed at ₹24,840.90, a +0.01% gain for the day.
While the Nifty 50 held its own, there were some notable movers and shakers among individual stocks that contributed to today’s performance. Check out the table below for a closer look at the top gainers and losers.
Nifty 50 Top Gainers
Stock | Close | Range |
---|---|---|
Tata Motors | ₹1162 (3.38%) | ₹1,118.58 – ₹1179 |
NTPC | ₹406.7 (3.25%) | ₹397 – ₹412.7 |
Bharat Petroleum | ₹348.79 (3.22%) | ₹337.6 – ₹359.04 |
UPL | ₹564.9 (2.12%) | ₹552.84 – ₹568.7 |
Power Grid | ₹349.5 (2.08%) | ₹343.29 – ₹356.95 |
Nifty 50 Top Losers
Stock | Close | Range |
---|---|---|
LTIMindtree | ₹5,672.5 (-1.98%) | ₹5,659.95 – ₹5797 |
Sun Pharma | ₹1,697.9 (-1.48%) | ₹1697 – ₹1,725.44 |
SBI Life Insurance | ₹1,721.05 (-1.47%) | ₹1708 – ₹1,746.3 |
Britannia | ₹5,842.2 (-0.94%) | ₹5,831.29 – ₹5,989.39 |
Hindalco | ₹661 (-0.88%) | ₹655 – ₹664.45 |
Nifty 50 Stocks To Watch for Tomorrow
Bharat Petroleum (Bullish Pattern)
- Performance Overview: Over the past 26 trading days, Bharat Petroleum closed higher 17 times and lower 9 times. This indicates a strong upward trend.
- Recent Trend: Bharat Petroleum has been on a 5-day winning streak, closing higher each day since Tuesday, July 23, 2024.
- Returns: In the last 26 trading sessions, Bharat Petroleum delivered a solid 12.62% return. If you had invested ₹10,000, it would be worth ₹11,261.99 today.
- Financial Insight: In the past year, Bharat Petroleum has generated a remarkable ₹4,50,427.87 Crore in revenue and earned a profit of ₹19,056.08 Crore.
- As of Tuesday, July 30, 2024, Bharat Petroleum has a Market Capital of ₹1,42,650.19 Crore.
- Summary: Bharat Petroleum shows a strong bullish pattern. Investors should keep a close eye on its price movements to identify potential opportunities for both short-term and long-term growth. To see potential price targets for tomorrow and for the rest of 2024 and 2025, check out: Bharat Petroleum Target for Tomorrow and Bharat Petroleum Targets for 2024 & 2025.
Bharat Petroleum Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 1,42,650.19 Crore | Market valuation of Bharat Petroleum’s shares. |
Revenue (TTM) | 4,50,427.87 Crore | Total revenue generated by Bharat Petroleum over the past twelve months. |
Net Income (TTM) | +19,056.08 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 3.48% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 4.23% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +0.1% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | -73.3% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 72.18 | Company’s total debt divided by total shareholder equity. |
Total Debt | 54,599.05 Crore | Sum of Bharat Petroleum’s current & long-term financial obligations. |
Total Cash | 10,577.03 Crore | Total amount of liquid funds available to Bharat Petroleum. |
Beta | 1.07 | Beta is greater than 1 indicating that the Bharat Petroleum’s price is more volatile than the market. |
➲ Nestle India (Bearish Trend)
- Performance Overview: In the last 26 trading days, Nestle India closed lower 15 times and higher 11 times.
- Recent Trend: Nestle India has been on a downward trend for the past 8 days, with no gains since Thursday, July 18, 2024.
- Returns: Nestle India has seen a -1.58% return over the past 26 trading days. This means an initial investment of ₹10,000 would be worth ₹9,842 today.
- Financial Snapshot: Over the past 12 months, Nestle India generated revenue of ₹19,665.02 Crore and achieved a profit of ₹3,244.46 Crore.
- As of Tuesday, July 30, 2024, Nestle India has a Market Capitalization of ₹2,38,812.03 Crore.
- Summary: Nestle India is currently in a bearish phase. We recommend investors keep a close eye on the stock’s performance, especially its projected price for tomorrow and its estimated price targets for 2024 and 2025.
Nestle India Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 2,38,812.03 Crore | Market valuation of Nestle India’s shares. |
Revenue (TTM) | 19,665.02 Crore | Total revenue generated by Nestle India over the past twelve months. |
Net Income (TTM) | +3,244.46 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 20.55% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 16.49% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +3.3% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +6.9% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 10.31 | Company’s total debt divided by total shareholder equity. |
Total Debt | 344.76 Crore | Sum of Nestle India’s current & long-term financial obligations. |
Total Cash | 798.84 Crore | Total amount of liquid funds available to Nestle India. |
Beta | 0.06 | Beta is less than 1 indicating that the Nestle India’s price is less volatile than the market. |
Nifty 500 Performance Overview
The Nifty 500 kicked off the day at ₹23,421.19. Throughout the trading session, it went on a bit of a roller coaster ride, hitting a low of ₹23,381.34 and reaching a high of ₹23,530 before finally settling at a close of ₹23,440.9 (+0.19%).
The day’s movement was influenced by the top gainers and losers, which you can find in the table below.
Nifty 500 Top Gainers
Stock | Close | Range |
---|---|---|
PCBL | ₹331.39 (10.57%) | ₹305.1 – ₹343.45 |
CAMS | ₹4,695.04 (9.57%) | ₹4290 – ₹4725 |
Fine Organics | ₹5,872.64 (9.43%) | ₹5,285.95 – ₹5,958.85 |
Polyplex Corporation | ₹1,179.25 (9.37%) | ₹1080 – ₹1195 |
NYKAA | ₹198.89 (8.77%) | ₹182.61 – ₹201.89 |
Nifty 500 Top Losers
Stock | Close | Range |
---|---|---|
CSB Bank | ₹330.25 (-4.15%) | ₹328 – ₹352 |
Exide | ₹532 (-3.61%) | ₹530 – ₹554.84 |
Suprajit Engineering | ₹524.79 (-3.09%) | ₹523.84 – ₹541.95 |
Poonawalla Fincorp | ₹370 (-2.9%) | ₹369.75 – ₹385.45 |
Network18 Media & Investments | ₹90.97 (-2.77%) | ₹89.98 – ₹94.47 |
Nifty 51 to 500 Stocks To Watch for Tomorrow
Ajanta Pharma: A Look at the Bullish Trend
- Performance Overview: Over the last 26 trading sessions (ending on July 30, 2024), Ajanta Pharma has shown a strong performance, closing higher on 16 days and lower on 10. This positive trend indicates potential for growth.
- Recent Trend: The stock has been on an impressive 9-day green streak, with no red days since July 16, 2024. This sustained upward movement is a clear bullish signal.
- Returns: In the past 26 trading sessions, Ajanta Pharma has delivered a solid 8.14% return. This means an investment of ₹10,000 would have grown to ₹10,814 during this period.
- Financial Insight: Ajanta Pharma’s financial performance has been strong. Over the past 12 months, the company generated ₹4,208.71 Crore in revenue and a profit of ₹816.16 Crore. This robust financial health is a positive indicator for future growth.
- Market Capitalization: As of July 30, 2024, Ajanta Pharma’s market capitalization stood at ₹29,993.72 Crore, reflecting the value investors place on the company.
- Summary: Ajanta Pharma exhibits a clear bullish pattern, making it an attractive stock to watch. Investors may want to consider both short-term and long-term growth opportunities. Check out our analysis of Ajanta Pharma’s potential for tomorrow and its targets for 2024 and 2025 for a more in-depth view.
Ajanta Pharma Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 29,993.72 Crore | Market valuation of Ajanta Pharma’s shares. |
Revenue (TTM) | 4,208.71 Crore | Total revenue generated by Ajanta Pharma over the past twelve months. |
Net Income (TTM) | +816.16 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 24.01% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 19.39% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +19.5% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +65.8% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 1.03 | Company’s total debt divided by total shareholder equity. |
Total Debt | 36.84 Crore | Sum of Ajanta Pharma’s current & long-term financial obligations. |
Total Cash | 459.54 Crore | Total amount of liquid funds available to Ajanta Pharma. |
Beta | 0.04 | Beta is less than 1 indicating that the Ajanta Pharma’s price is less volatile than the market. |
➲ Poly Medicure (Bearish Trend)
- Performance Overview: In the last 26 trading days, Poly Medicure closed lower than the previous day 17 times and higher 9 times. This tells us that the stock has been moving downwards more often than upwards.
- Recent Trend: Poly Medicure has been on a downward trend for the past 9 trading days, with no gains since Tuesday, July 16th, 2024.
- Returns: Over the past 26 trading days, Poly Medicure has lost 4.57%. If you had invested ₹10,000 in the stock, you would now have ₹9,543.
- Financial Insight: Over the past 12 months, Ajanta Pharma generated ₹1,375.79 Crore in revenue and a profit of ₹258.25 Crore.
- As of Tuesday, July 30th, 2024, Ajanta Pharma has a Market Capital of ₹17,404.89 Crore.
- Summary: Poly Medicure is currently experiencing a downward trend. We advise investors to carefully monitor the stock’s performance. You might want to check out Poly Medicure’s Target for Tomorrow and Poly Medicure’s Targets for 2024 & 2025 for more insight.
Poly Medicure Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 17,404.89 Crore | Market valuation of Poly Medicure’s shares. |
Revenue (TTM) | 1,375.79 Crore | Total revenue generated by Poly Medicure over the past twelve months. |
Net Income (TTM) | +258.25 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 21.26% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 18.77% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +23.2% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +16.2% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 11.84 | Company’s total debt divided by total shareholder equity. |
Total Debt | 174.15 Crore | Sum of Poly Medicure’s current & long-term financial obligations. |
Total Cash | 286.39 Crore | Total amount of liquid funds available to Poly Medicure. |
Beta | 0.34 | Beta is less than 1 indicating that the Poly Medicure’s price is less volatile than the market. |
Top Stocks That Created a New All Time High Today
Top Large Cap Stocks That Created a New All Time High Today
Companies with Market Capital more than 20,000 CroresStock | Close | New All-Time High (ATH) | Previous ATH | Previous ATH Date |
---|---|---|---|---|
Affle | 1479.69 (-1.13%) | 1517.00 (+%) | Thu 01 Jan 1970 | |
Ajanta Pharma | 2530.55 (+4.63%) | 2579.89 (+%) | Thu 01 Jan 1970 | |
Aurobindo Pharma | 1399.44 (-0.4%) | 1423.05 (+%) | Thu 01 Jan 1970 | |
Colgate Palmolive | 3366.55 (+4.87%) | 3424.94 (+21.67%) | 2814.89 | Wed 03 Apr 2024 |
Coromandel International | 1661.34 (-1.12%) | 1693.55 (+%) | Thu 01 Jan 1970 |
Top Mid Cap Stocks That Created a New All Time High Today
Companies with Market Capital between 5,000 Crores to 20,000 CroresStock | Close | New All-Time High (ATH) | Previous ATH | Previous ATH Date |
---|---|---|---|---|
Black Box | 488.00 (+3.16%) | 496.70 (+%) | Thu 01 Jan 1970 | |
Blue Jet Healthcare | 455.35 (+2.42%) | 470.00 (+%) | Thu 01 Jan 1970 | |
CAMS | 4695.04 (+9.57%) | 4725.00 (+%) | Thu 01 Jan 1970 | |
ELANTAS Beck India | 12772.15 (+0.79%) | 12990.00 (+30.03%) | 9990.00 | Mon 01 Apr 2024 |
Electrosteel Castings | 217.70 (+3.63%) | 221.39 (+7.47%) | 206.00 | Mon 22 Apr 2024 |
Top Small Cap Stocks That Created a New All Time High Today
Companies with Market Capital less than 5,000 CroresStock | Close | New All-Time High (ATH) | Previous ATH | Previous ATH Date |
---|---|---|---|---|
21ST CENTURY MANAG | 81.34 (+1.99%) | 81.34 (+%) | Thu 01 Jan 1970 | |
Ahmedabad Steelcraft | 155.89 (+1.99%) | 155.89 (+%) | Thu 01 Jan 1970 | |
BALUFORGE | 491.45 (+4.64%) | 512.40 (+%) | Thu 01 Jan 1970 | |
BCC Fuba India | 106.30 (+4.99%) | 106.30 (+%) | Thu 01 Jan 1970 | |
BDH Industries | 402.10 (+17.71%) | 407.64 (+%) | Thu 01 Jan 1970 |